Validation of the European Association for the Study of the Liver algorithm for the noninvasive diagnosis of advanced fibrosis in metabolic-dysfunction associated steatotic liver disease

被引：0
|
作者：
Kalligeros, Markos [1 ]
Tsochatzis, Emmanuel A. [2 ,3 ,4 ,5 ]
机构：
[1] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Div Internal Med, Providence, RI USA
[2] Royal Free Hosp, UCL Inst Liver & Digest Hlth, London, England
[3] UCL, London, England
[4] Royal Free Hosp, Sheila Sherlock Liver Unit, London, England
[5] Royal Free Hosp, Sheila Sherlock Liver Unit, Pond St, London NW3 2QG, England
来源：
HEPATOBILIARY SURGERY AND NUTRITION | 2024年 / 13卷 / 02期
关键词：
Fibroscan; enhanced liver fibrosis (ELF); fibrosis-4 (FIB-4); cirrhosis; metabolic-dysfunction associated steatotic liver disease (MASLD); METASTATIC COLORECTAL-CANCER; SIDED COLON-CANCER;
D O I：
10.21037/hbsn-23-654
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：311 / 313
页数：3
相关论文
共 50 条
  • [41] Advancing towards accurate phenotyping based on metabolic and fibrosis risk in metabolic-dysfunction associated steatotic liver disease: one step closer to personalized care
    Munoz-Martinez, Sergio
    Jimenez-Masip, Alba
    Pericas, Juan M.
    HEPATOBILIARY SURGERY AND NUTRITION, 2024, 13 (01) : 128 - 131
  • [42] SCREENING FOR ADVANCED FIBROSIS AMONG ALASKA NATIVE PEOPLES WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
    Johnston, Janet
    Barbour, Youssef
    Townshend-Bulson, Lisa
    Desai, Kena
    Homan, Chriss
    Rhodes, Wileina
    McMahon, Brian
    HEPATOLOGY, 2024, 80 : S558 - S559
  • [43] Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease
    Michalczuk, Matheus Truccolo
    Longo, Larisse
    Keingeski, Melina Belen
    Basso, Bruno de Souza
    Guerreiro, Gabriel Tayguara Silveira
    Ferrari, Jessica T.
    Vargas, Jose Eduardo
    Oliveira, Claudia P.
    Uribe-Cruz, Carolina
    Cerski, Carlos Thadeu Schmidt
    Filippi-Chiela, Eduardo
    Alvares-da-Silva, Mario Reis
    WORLD JOURNAL OF HEPATOLOGY, 2024, 16 (01) : 75 - 90
  • [44] Long term outcomes of Saroglitazar in metabolic-dysfunction associated steatotic liver disease related cirrhosis-a prospective cohort study
    Maiwall, Rakhi
    Chauhan, Neha
    Sharma, Priyanka
    JOURNAL OF HEPATOLOGY, 2024, 80 : S605 - S606
  • [45] Evaluation of liver fibrosis and steatohepatitis associated with metabolic dysfunction (MASH) in patients with inflammatory bowel disease (IBD) and steatotic liver disease associated with metabolic dysfunction (MASLD)
    Oliveira, E. C. S. D.
    Lopes, M. A.
    Beraldo, R. F.
    Castelhano, N. S.
    Baima, J. P.
    Herrerias, G. S. P.
    Quaglio, A. E., V
    Di Stasi, L. C.
    Barbosa, W. F.
    Silva, G. F.
    Sassaki, L. Y.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i666 - i666
  • [46] The association between estimated glucose disposal rate and metabolic dysfunction-associated steatotic liver disease and liver fibrosis in US adults
    Liu, Wanqian
    Li, Xiaozhong
    Chen, Ling
    Luo, Xiao
    BMC ENDOCRINE DISORDERS, 2025, 25 (01)
  • [47] The association between non-invasive tests of liver fibrosis and early diastolic dysfunction in patients with Metabolic Dysfunction-Associated Steatotic Liver Disease
    Amato, F.
    Armandi, A.
    Andreis, A.
    Bellettini, M.
    Lorusso, F.
    Gjini, K.
    Marano, M.
    Vaira, L.
    Rosso, C.
    Caviglia, G. P.
    Guariglia, M.
    Dileo, E.
    Castagno, D.
    Alunni, G.
    De Ferrari, G. M.
    Bugianesi, E.
    DIGESTIVE AND LIVER DISEASE, 2025, 57
  • [48] Molecular pathogenesis of metabolic dysfunction-associated steatotic liver disease, steatohepatitis, hepatic fibrosis and liver cirrhosis
    Saito, Takashi
    Tsuchishima, Mutsumi
    Tsutsumi, Mikihiro
    George, Joseph
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (12)
  • [49] Investigating the postprandial metabolic and inflammatory phenotypes of healthy subjects and patients with metabolic dysfunction-associated steatotic liver disease and metabolic-dysfunction associated steatohepatitis to understand disease progression
    Mullin, Sinead M.
    Shannon, Christopher E.
    Ni Chathail, Meabh B.
    Singh, Pamla
    Norris, Suzanne
    Roche, Helen M.
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2024, 83 (OCE4)
  • [50] RELEVANCE OF MAST CELLS IN THE ADVANCED STAGES OF METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
    Francois, Dannette Guinez
    Favi, Javiera
    Pinto, Araceli
    Jeria, Fernanda
    Zazueta, Alejandra
    Campusano, Benjamin
    Carreno-Toro, Laura
    Aleman, Larissa V.
    Magne, Fabien
    Roblero, Juan Pablo
    Poniachik, Jaime
    Beltran, Caroll J.
    GASTROENTEROLOGY, 2024, 166 (05) : S1640 - S1640
12345